ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Cadaveric organs"

  • 2021 American Transplant Congress

    Outcomes of Kidney Transplant Recipients (KTRs) Comparing Brain Dead Donors’ vs Donation After Cardiac Death Stratified by KDPI, Focus on Marginal Kidneys: A UNOS Database Analysis

    B. Chopra1, K. K. Sureshkumar1, D. Rajasundaram2, E. C. Rodrigo3

    1Allegheny Health Network, Pittsburgh, PA, 2UPMC, Pittsburgh, PA, 3University Hospital Marqués de Valdecilla, Santander, Spain

    *Purpose: In deceased donor kidney transplantation (DDKT), donation after cardiac death (DCD) is associated with increased cytokine release and renal tubular injury with consequent increase…
  • 2021 American Transplant Congress

    Outcomes of Abdominal Transplant Recipients Who Receive Organs from Donors with Positive Cultures

    A. Perez Cortes Villalobos, A. Humar, D. Kumar

    University Health Network, Toronto, ON, Canada

    *Purpose: Due to limited organ availability, use of donors with positive bacterial cultures is common practice. One of the main concerns is transmission to the…
  • 2021 American Transplant Congress

    Superior Post-transplant Clinical Outcomes Using Portable Normothermic Perfusion and Assessment with the Organ Care System (ocs) Liver System: 1-year Outcomes of the Ocs Liver Protect Randomized Controlled Trial

    J. Markmann1, M. Abouljoud2, M. Ghobrial3, C. Bhati4, S. Pelletier5, J. Magliocca6, T. Pruett7, A. Lu8, M. Rizzari9, S. Ottmann10, T. Klair11, C. Eymard12, G. Roll13, G. Reyes14, S. Black15, S. Florman16, S. Mirani17, C. Marsh18, G. Schnickel19, M. Kinkhabwala20, A. Demetris21, H. Yeh22, P. Vagefi23, M. MacConmara23

    1MGH, Boston, MA, 2Henry Ford, Detroit, MI, 3Houston Methodist, Houston, TX, 4Virginia Commonwealth, Richmond, VA, 5UVA, Charlottesville, VA, 6Emory, Atlanta, GA, 7U. Minnesota, Minneapolis, MN, 8Tampa General, Tampa, FL, 9Henry Ford, Detriot, MI, 10Johns Hopkins, Baltimore, MD, 11University of Texas HSC, San Antonio, TX, 12University of Tennessee HSC, Memphis, TN, 13UCSF, San Francisco, CA, 14U. Washington, Seattle, WA, 15Ohio State, Columbus, OH, 16Mt. Sinai, New York, NY, 17U. Nebraska, Omaha, NE, 18Scripps Clinic, San Diego, CA, 19U. San Diego, San Diego, CA, 20Montefiore, New York, MA, 21UPMC, Pittsburgh, PA, 22Massachusetts General Hospital, Boston, MA, 23UT Southwestern, Dallas, TX

    *Purpose: The OCS Liver PROTECT Trial was the first U.S. randomized controlled trial for liver perfusion and was designed to evaluate the impact of portable…
  • 2021 American Transplant Congress

    Association of Donor Hepatitis C Virus Infection Status and Risk of Bk Polyomavirus Viremia After Kidney Transplantation

    V. S. Potluri1, D. E. Schaubel1, M. E. Sise2, B. P. Concepcion3, R. C. Forbes1, E. A. Blumberg1, D. Goldberg4, P. P. Reese1, R. Bloom1, D. Shaffer3, R. Chung2, D. Sawinski1, I. Strohben2, N. Elias2, A. Azhar5, M. Shah1, J. Eason5, L. A. Binari3, M. Talwar5, V. Balaraman5, A. Bhalla5, B. Besharatian1, M. Z. Molnar5

    1University of Pennsylvania, Philadelphia, PA, 2Massachusetts General Hospital, Boston, MA, 3Vanderbilt University Medical Center, Nashville, TN, 4University of Miami Miller School of Medicine, Miami, FL, 5Methodist University Hospital, Memphis, TN

    *Purpose: Transplantation of kidneys from deceased donors with hepatitis C virus (HCV) infection into HCV-negative recipients has become more common, but some studies have suggested…
  • 2021 American Transplant Congress

    Use of Donor Blood Expedites HCV Genotyping and Allows Earlier DAA Initiation for Recipients of HCV+ Kidneys

    B. Lonze, N. Ali, R. Montgomery, Z. Stewart Lewis

    Tranplant Institute, NYU Langone Health, New York, NY

    *Purpose: Utilization of HCV viremic donor kidneys for transplant into HCV naïve recipients has become more widespread, yet best practices governing the initiation, timing or…
  • 2021 American Transplant Congress

    Cleveland Clinic Experience with Cadaveric Uterus Transplant

    L. Del Prete1, C. Quintini1, K. Hashimoto1, B. Eghtesad1, G. D'Amico1, C. Kwon1, D. Priebe1, E. Richards1, S. Ricci1, U. Perni1, C. Ferrando1, A. Chiesa-Vottero1, S. Mawhorter1, N. Yeaney1, R. Farrell1, R. Flyckt2, C. Miller1, T. Falcone1, A. Tzakis1

    1Cleveland Clinic, Cleveland, OH, 2University Hospital, Cleveland, OH

    *Purpose: Uterus transplantation (UTx) is the only treatment for women with uterine factor infertility (UFI). The majority of overall experience is from living donation. Little…
  • 2021 American Transplant Congress

    Kidney Programs Can Filter Off a Majority of Their Unwanted Organ Offers without Harming Transplant Volumes

    A. Toll, H. McGehee, R. McTier, D. Stewart

    Research, United Network for Organ Sharing, Richmond, VA

    *Purpose: Evaluate if multifactorial filters can reduce unwanted kidney offers to centers, thereby reducing administrative burden and getting to the accepting candidate quicker.*Methods: 34 centers…
  • 2021 American Transplant Congress

    Covid Studies in 208 Patients with Consent for Donation

    A. L. Friedman, C. Ezzell, K. Delli Carpini

    LiveOnNY, New York, NY

    *Purpose: To prevent transmission of SARS CoV 2 via solid organ donation from deceased donors.*Methods: Comprehensive medical and psychosocial evaluation of potential deceased organ donors…
  • 2021 American Transplant Congress

    Not Always as it Seems: Lack of Hepatitis C Virus Transmission from Nucleic Acid Testing Positive Deceased Donors

    A. Nishio Lucar1, A. Kumar1, S. Rao1, V. L. Kelly1, K. Coles2, J. Kamal1, C. W. Green1, A. M. Doyle1

    1Medicine, University of Virginia, Charlottesville, VA, 2University of Virginia, Charlottesville, VA

    *Purpose: Hepatitis C virus (HCV) + organs are increasingly use to transplant HCV naive candidates with good short-term outcomes. HCV transmission with HCV nucleic acid…
  • 2021 American Transplant Congress

    Sharing Under KAS – What is the Impact According to KDPI?

    M. Jacobs, R. Stratta, C. Jay

    Wake Forest Baptist Health, Winston Salem, NC

    *Purpose: The new Kidney Allocation System (KAS) implemented in 2014 was designed to facilitate sharing of kidneys due to changes in prioritization of highly sensitized…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences